TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pharmaq AS
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
147,370
|
122,766
|
111,827 |
Financial expenses |
7,602
|
8
|
139 |
Earnings before taxes |
73,402
|
54,547
|
58,199 |
Total assets |
269,320
|
215,529
|
166,332 |
Current assets |
229,044
|
165,433
|
123,348 |
Current liabilities |
37,104
|
27,752
|
27,535 |
Equity capital |
232,132
|
186,797
|
137,314 |
- share capital |
1,631
|
1,721
|
1,633 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
86.2%
|
86.7%
|
82.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
49.8%
|
44.4%
|
52.0% |
Return on assets (ROA) |
30.1%
|
25.3%
|
35.1% |
Current ratio |
617.3%
|
596.1%
|
448.0% |
Return on equity (ROE) |
31.6%
|
29.2%
|
42.4% |
Change turnover |
31,052
|
4,864
|
6,871 |
Change turnover % |
27%
|
4%
|
7% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.